CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial
Abstract Background Cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP)/CHOP-like chemotherapy is widely used in peripheral T cell lymphoma (PTCL). Here we conducted a phase 2, multicenter, randomized, controlled trial, comparing the efficacy and safety of CEOP/IVE/GDP alternating re...
Main Authors: | Ming-Ci Cai, Shu Cheng, Xin Wang, Jian-Da Hu, Yong-Ping Song, Yao-Hui Huang, Zi-Xun Yan, Yu-Jie Jiang, Xiao-Sheng Fang, Xiao-Yun Zheng, Li-Hua Dong, Meng-Meng Ji, Li Wang, Peng-Peng Xu, Wei-Li Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Genome Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13073-020-00739-0 |
Similar Items
-
Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study
by: Linghua Zhu, et al.
Published: (2020-11-01) -
Development of an interface for the conversion of geodata in a NetCDF data model and publication of this data by the use of the web application DChart, related to the CEOP-AEGIS project
by: Holzer, Nicolai
Published: (2011) -
Peripheral T-cell lymphoma, not otherwise specified
by: Kunal Kishor Jha, et al.
Published: (2017-01-01) -
Efficacy on chopping with lens loop-pad in the small incision extracapsular cataract surgery with intraocular lens implantation
by: Xiao-Ning Peng, et al.
Published: (2014-04-01) -
First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis
by: Zhang S, et al.
Published: (2018-11-01)